Lessons From Biotech Entrepreneurs: Pitching Your First-In-Class Innovation

Scientific Leaders From Nurix, Arrakis And Strand Therapeutics On Hitting ‘Undruggable’ Targets

The role of biopharma start-ups in bringing innovative therapies to the market has grown enormously. These waves of new specialist companies often have the most innovative approaches to targeting a disease, and big pharma has become increasingly reliant on their fresh ideas to power pipelines. 

Arrow flying to target with radial motion blur
Hitting emerging targets in R&D • Source: Shutterstock

What does it take to lead a biotech start-up in 2020? Three start-up leaders with companies illustrating different stages of the early biopharma lifecycle give their insights:

The role of biopharma start-ups in bringing innovative therapies to the market has grown enormously in recent years. These waves...

More from Business Strategy

More from In Vivo

Deals In Depth: June 2025

 
• By 

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By 

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By 

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.